Crossmark

An examination of the medicalization and pharmaceuticalization processes of anxiety and depressive disorders in Belgium between 2004 and 2013: how may both disorders be intertwined?

Crossref DOI link: https://doi.org/10.1186/s13690-022-00943-x

Published Online: 2022-08-15

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kilian, Van Looy

de Velde Sarah, Van
License Information

Text and Data Mining valid from 2022-08-15

Version of Record valid from 2022-08-15
More Information

Article History

Received: 21 January 2022

Accepted: 24 July 2022

First Online: 15 August 2022

Declarations

:

: This study has been approved by the appropriate ethics committee (EASHW at the University of Antwerp) and has therefore been performed in accordance with the ethical standards laid down in the 1694 Declaration of Helsinki and its later amendments.

: All participants gave informed consent to participate in this study. All personal details were omitted to guarantee complete anonymity.

: The authors have no competing interests to declare that are relevant to the content of this article.

Document is current

Any future updates will be listed below